Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6

References

• Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284–296. doi:10.3322/caac.2145629809280
   PubMed Web of Science ®Google Scholar
• Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huettner PC, Fasih N. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics. 2011;31:625–646. doi:10.1148/rg.31310506621571648
   PubMed Web of Science ®Google Scholar
• Moorman PG, Calingaert B, Palmieri RT, et al. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol. 2008;167:1059–1069. doi:10.1093/aje/kwn00618303003
   PubMed Web of Science ®Google Scholar
• Babic A, Harris HR, Vitonis AF, et al. Menstrual pain and risk of epithelial ovarian cancer: results from the ovarian cancer association consortium. Int J Cancer. 2018;142:460–469. doi:10.1002/ijc.3101028833087
   PubMed Web of Science ®Google Scholar
• Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer. 2010;10:803–808. doi:10.1038/nrc294620944665
   PubMed Web of Science ®Google Scholar
• Han BW, Chen YQ. Potential pathological and functional links between long noncoding RNAs and hematopoiesis. Sci Signal. 2013;6:re5. doi:10.1126/scisignal.200409923962981
   PubMed Web of Science ®Google Scholar
• Necsulea A, Soumillon M, Warnefors M, et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature. 2014;505:635–640. doi:10.1038/nature1294324463510
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159. doi:10.1038/nrg252119188922
   PubMed Web of Science ®Google Scholar
• Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23:1494–1504. doi:10.1101/gad.180090919571179
   PubMed Web of Science ®Google Scholar
• Zhuo W, Kang Y. Lnc-ing ROR1-HER3 and Hippo signalling in metastasis. Nat Cell Biol. 2017;19:81–83. doi:10.1038/ncb346728139652
   PubMed Web of Science ®Google Scholar
• Borcherding N, Kusner D, Liu GH, Zhang W. ROR1, an embryonic protein with an emerging role in cancer biology. Protein Cell. 2014;5:496–502. doi:10.1007/s13238-014-0059-724752542
   PubMed Web of Science ®Google Scholar
• Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–1076. doi:10.1038/nature0897520393566
   PubMed Web of Science ®Google Scholar
• Fu WM, Zhu X, Wang WM, et al. Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling. J Hepatol. 2015;63:886–895. doi:10.1016/j.jhep.2015.05.01626024833
   PubMed Web of Science ®Google Scholar
• Wang F, Yuan JH, Wang SB, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 2014;60:1278–1290. doi:10.1002/hep.2723925043274
   PubMed Web of Science ®Google Scholar
• Zhao J, Du P, Cui P, et al. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene. 2018;37:4094–4109. doi:10.1038/s41388-018-0250-z29706652
   PubMed Web of Science ®Google Scholar
• Gao Y, Meng H, Liu S, et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2015;24:841–852. doi:10.1093/hmg/ddu50225292198
   PubMed Web of Science ®Google Scholar
• Rangel LB, Sherman-Baust CA, Wernyj RP, Schwartz DR, Cho KR, Morin PJ. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene. 2003;22:7225–7232. doi:10.1038/sj.onc.120700814562052
   PubMed Web of Science ®Google Scholar
• Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52:101–112. doi:10.1016/j.molcel.2013.08.02724055342
   PubMed Web of Science ®Google Scholar
• Zhang TJ, Zhou JD, Zhang W, et al. H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia. Clin Epigenetics. 2018;10:47. doi:10.1186/s13148-018-0486-z29643943
   PubMed Web of Science ®Google Scholar
• Jin L, Cai Q, Wang S, et al. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer. Cell Death Dis. 2018;9:1017. doi:10.1038/s41419-018-1064-130282996
   PubMed Web of Science ®Google Scholar
• Liu C, Yang Z, Deng Z, et al. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3. IUBMB Life. 2018;70:536–546. doi:10.1002/iub.v70.629707897
   PubMed Web of Science ®Google Scholar
• Cao B, Liu C, Yang G. Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway. Biomed Pharmacother. 2018;107:185–193. doi:10.1016/j.biopha.2018.06.14630089248
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Z, Yao B, et al. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer. 2017;16:123. doi:10.1186/s12943-017-0702-z28716020
   PubMed Web of Science ®Google Scholar
• Hill CG, Matyunina LV, Walker D, Benigno BB, McDonald JF. Transcriptional override: a regulatory network model of indirect responses to modulations in microRNA expression. BMC Syst Biol. 2014;8:36. doi:10.1186/1752-0509-8-3624666724
   PubMed Web of Science ®Google Scholar
• Huang C, Clayton EA, Matyunina LV, et al. Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy. Sci Rep. 2018;8:16444. doi:10.1038/s41598-018-34753-530401894
   PubMed Web of Science ®Google Scholar
• Lili LN, Matyunina LV, Walker LD, Benigno BB, McDonald JF. Molecular profiling predicts the existence of two functionally distinct classes of ovarian cancer stroma. Biomed Res Int. 2013;(2013):846387.23762861
   PubMed Web of Science ®Google Scholar
• Yeung TL, Leung CS, Wong KK, et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013;73:5016–5028. doi:10.1158/0008-5472.CAN-13-002323824740
   PubMed Web of Science ®Google Scholar
• Mateescu B, Batista L, Cardon M, et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med. 2011;17:1627–1635. doi:10.1038/nm.251222101765
   PubMed Web of Science ®Google Scholar
• Seike M, Kim CH, Zou F, et al. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier. Oncol Rep. 2017;37:3261–3269. doi:10.3892/or.2017.559428440492
   PubMed Web of Science ®Google Scholar
• Roberts CM, Tran MA, Pitruzzello MC, et al. TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling. Sci Rep. 2016;6:37652. doi:10.1038/srep3765227876874
   PubMed Web of Science ®Google Scholar
• Antony J, Tan TZ, Kelly Z, et al. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. Sci Signal. 2016;9:ra97. doi:10.1126/scisignal.aaf817527703030
   PubMed Web of Science ®Google Scholar
• Wang C, Jin H, Wang N, et al. Gas6/Axl axis contributes to chemoresistance and metastasis in breast cancer through Akt/GSK-3beta/beta-catenin signaling. Theranostics. 2016;6:1205–1219. doi:10.7150/thno.1508327279912
   PubMed Web of Science ®Google Scholar
• Okazaki Y, Furuno M, Kasukawa T, et al. Team, analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420:563–573.12466851
   PubMed Web of Science ®Google Scholar
• Lagarde J, Uszczynska-Ratajczak B, Carbonell S, et al. High-throughput annotation of full-length long noncoding RNAs with capture long-read sequencing. Nat Genet. 2017;49:1731–1740.29106417
   PubMed Web of Science ®Google Scholar
• Kim J, Piao HL, Kim BJ, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50:1705–1715. doi:10.1038/s41588-018-0252-330349115
   PubMed Web of Science ®Google Scholar
• Gordon MA, Babbs B, Cochrane DR, Bitler BG, Richer JK. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing. Mol Carcinog. 2018; 58(2):196–205.30294913
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang L, Mei Z, et al. Interaction of E3 ubiquitin ligase MARCH7 with long noncoding RNA MALAT1 and autophagy-related protein ATG7 promotes autophagy and invasion in ovarian cancer. Cell Physiol Biochem. 2018;47:654–666. doi:10.1159/00049002029794480
   PubMedGoogle Scholar
• Zheng ZG, Xu H, Suo SS, et al. The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer. Sci Rep. 2016;6:26093. doi:10.1038/srep2609327193186
   PubMed Web of Science ®Google Scholar
• Ozes AR, Miller DF, Ozes ON, et al. NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35:5350–5361. doi:10.1038/onc.2016.7527041570
   PubMed Web of Science ®Google Scholar
• Gao H, Li X, Zhan G, et al. Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis. Cell Cycle. 2019;18:1393–1406. doi:10.1080/15384101.2019.161812131122127
   PubMed Web of Science ®Google Scholar
• Yong W, Yu D, Jun Z, et al. Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer. Cell Death Dis. 2018;9:861. doi:10.1038/s41419-018-0908-z30154460
   PubMed Web of Science ®Google Scholar
• Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene. 2003;22:5208–5219. doi:10.1038/sj.onc.120655812910258
   PubMed Web of Science ®Google Scholar
• Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7:812–821. doi:10.1101/gad.7.5.8128491378
   PubMed Web of Science ®Google Scholar
• Zhao S, Yi M, Yuan Y, et al. Expression of AKAP95, Cx43, CyclinE1 and CyclinD1 in esophageal cancer and their association with the clinical and pathological parameters. Int J Clin Exp Med. 2015;8:7324–7332.26221272
   PubMed Web of Science ®Google Scholar
• Lamb J, Ramaswamy S, Ford HL, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell. 2003;114:323–334. doi:10.1016/S0092-8674(03)00570-112914697
   PubMed Web of Science ®Google Scholar
• Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701–704. doi:10.1038/366701a08259214
   PubMed Web of Science ®Google Scholar
• Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400–414. doi:10.1038/nrc265719440234
   PubMed Web of Science ®Google Scholar
• Mandal M, Bandyopadhyay D, Goepfert TM, Kumar R. Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK). Oncogene. 1998;16:217–225. doi:10.1038/sj.onc.12015299464540
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments. Cell Cycle. 2011;10:2497–2503. doi:10.4161/cc.10.15.1677621775818
   PubMed Web of Science ®Google Scholar
• Angelillo-Scherrer A, de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med. 2001;7:215–221. doi:10.1038/8466711175853
   PubMed Web of Science ®Google Scholar
• Laurance S, Lemarie CA, Blostein MD. Growth arrest-specific gene 6 (gas6) and vascular hemostasis. Adv Nutr. 2012;3:196–203. doi:10.3945/an.111.00182622516727
   PubMed Web of Science ®Google Scholar
• Lee CH, Chu NF, Shieh YS, Hung YJ. The growth arrest-specific 6 (Gas6) gene polymorphism c.834+7G>A is associated with type 2 diabetes. Diabetes Res Clin Pract. 2012;95:201–206. doi:10.1016/j.diabres.2011.09.01321959217
   PubMed Web of Science ®Google Scholar
• Kariolis MS, Miao YR, Diep A, et al. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest. 2017;127:183–198. doi:10.1172/JCI8561027893463
   PubMed Web of Science ®Google Scholar
• Shiozawa Y, Pedersen EA, Patel LR, et al. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. Neoplasia. 2010;12:116–127. doi:10.1593/neo.9138420126470
   PubMed Web of Science ®Google Scholar